Department of Traditional Chinese Medicine, Shanghai Jiao Tong University Affiliated Sixth People's Hospital, Shanghai, 200233, China.
Queen Mary School, Nanchang University, Nanchang City, Jiangxi Province, 330031, China.
Nutr Diabetes. 2018 Sep 24;8(1):53. doi: 10.1038/s41387-018-0061-x.
L-cell dysfunction is reported for GLP-1 reduction in type 2 diabetes. However, the mechanism of dysfunction remains unknown. In this study, we examined mitochondrial function in the mechanistic study in diet-induced obese (DIO) mice.
C57BL/6 mice were fed a high-fat diet (HFD) for 16 weeks to establish the DIO model for GLP-1 reduction. The mice were then treated with berberine (BBR) (100 mg/kg/day) for 8 weeks to test the impact on GLP-1 expression. Mitochondrial activities of the colon enterocytes were compared among three groups of mice (lean, DIO, and DIO + BBR) at the end of treatment. Gut microbiota and short-chain fatty acids (SCFAs) were examined to understand the mitochondrial responses. A cellular model treated with palmitic acid (PA) was used in the mechanism study.
A reduction in GLP-1 expression was observed in DIO mice with mitochondrial stress responses in the colon enterocytes. The mitochondria exhibited cristae loss, membrane rupture, and mitochondrial swelling, which was observed with an increase in ATP abundance, complex I activity, and deficiency in the activities of complexes II and IV. Those changes were associated with dysbiosis and a reduction in SCFAs in the colon of DIO mice. In the cellular model, an increase in ATP abundance, loss of mitochondrial potential, and elevation of apoptosis were induced by PA. All of the alterations in DIO mice and the cellular model were attenuated by BBR.
The mitochondrial stress responses were observed in the colon enterocytes of DIO mice for GLP-1 reduction. The stress was prevented by BBR in the restoration of GLP-1 expression, in which BBR may act through direct and indirect mechanisms.
有报道称,2 型糖尿病患者 GLP-1 减少与 L 细胞功能障碍有关。然而,其功能障碍的机制尚不清楚。在这项研究中,我们在饮食诱导肥胖(DIO)小鼠的机制研究中检查了线粒体功能。
C57BL/6 小鼠喂食高脂肪饮食(HFD)16 周,建立 GLP-1 减少的 DIO 模型。然后,用黄连素(BBR)(100mg/kg/天)治疗 8 周,以测试其对 GLP-1 表达的影响。治疗结束时,比较三组小鼠(瘦鼠、DIO 鼠和 DIO+BBR 鼠)结肠肠上皮细胞的线粒体活性。检查肠道微生物群和短链脂肪酸(SCFAs)以了解线粒体的反应。用棕榈酸(PA)处理细胞模型用于机制研究。
DIO 小鼠的 GLP-1 表达减少,结肠肠上皮细胞出现线粒体应激反应。线粒体表现出嵴丢失、膜破裂和线粒体肿胀,同时伴随着 ATP 含量增加、复合物 I 活性增加以及复合物 II 和 IV 活性降低。这些变化与 DIO 小鼠结肠的菌群失调和 SCFAs 减少有关。在细胞模型中,PA 诱导 ATP 含量增加、线粒体电位丧失和凋亡增加。BBR 可减轻 DIO 小鼠和细胞模型中的所有改变。
DIO 小鼠的结肠肠上皮细胞出现 GLP-1 减少的线粒体应激反应。BBR 通过恢复 GLP-1 表达来预防应激,BBR 可能通过直接和间接机制发挥作用。